Literature DB >> 14528964

Dosimetric characteristics of a low-kV intra-operative x-ray source: implications for use in a clinical trial for treatment of low-risk breast cancer.

M A Ebert1, B Carruthers.   

Abstract

The dosimetric characteristics of a low-kV x-ray device for performing intra-operative irradiations, the Intrabeam (Photoelectron Corporation, Lexington, MA), are examined. Two dosimetric models are considered--an analytical model considering only the primary x-ray beam, and a Monte Carlo model utilizing the EGSnrc code and a spherical simulation geometry. Both models prove reliable for verifying measured dose distributions for the device. The Monte Carlo model is necessary for examining spectral variations and the influence of inhomogeneities. The predictions of the Monte Carlo model are utilized to examine points of consideration for a multi-center clinical trial using the Intrabeam in the intra-operative, single fraction post-resection treatment of low-risk breast cancer. Predicted differences in radiological equivalence of breast tissue and water suggest a 3-5% under-dose of breast tissue (in a 50 kV beam) when dose fall-off data in water is used. A substantial dose enhancement in bone (i.e., ribs) adjacent to the treatment site is predicted though, based on published clinical data for radiation-induced rib fracture, it is concluded that induction of radiation-induced rib fracture would not pose a significant risk. Dose-volume changes with size of the treatment area (defined by the size of the resection volume) are examined indicating large variations in dose-volume characteristics across the range of possible "target" volumes.

Entities:  

Mesh:

Year:  2003        PMID: 14528964     DOI: 10.1118/1.1595611

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  14 in total

Review 1.  Electronic brachytherapy--current status and future directions.

Authors:  D J Eaton
Journal:  Br J Radiol       Date:  2015-03-06       Impact factor: 3.039

Review 2.  Intraoperative radiotherapy in early stage breast cancer: potential indications and evidence to date.

Authors:  G G Hanna; A M Kirby
Journal:  Br J Radiol       Date:  2015-03-03       Impact factor: 3.039

3.  Dosimetric characteristics of the INTRABEAM ® system with spherical applicators in the presence of air gaps and tissue heterogeneities.

Authors:  Eyachew Misganew Tegaw; Somayeh Gholami; Gilnaz Omyan; Ghazale Geraily
Journal:  Radiat Environ Biophys       Date:  2020-03-31       Impact factor: 1.925

4.  A portable organic plastic scintillator dosimetry system for low energy X-rays: A feasibility study using an intraoperative X-ray unit as the radiation source.

Authors:  Kerry Williams; Neil Robinson; Jamie Trapp; Trevor Ackerly; Ram Das; Penny Kemp; Moshi Geso
Journal:  J Med Phys       Date:  2007-04

5.  Functional intercomparison of intraoperative radiotherapy equipment - Photon Radiosurgery System.

Authors:  Kris S Armoogum; John M Parry; Salam K Souliman; David G Sutton; Colin D Mackay
Journal:  Radiat Oncol       Date:  2007-02-27       Impact factor: 3.481

6.  Modelling the radiobiological effect of intraoperative X-ray brachytherapy for breast cancer using an air-filled spherical applicator.

Authors:  Kris Armoogum; Simon Evans; David Morgan
Journal:  J Contemp Brachytherapy       Date:  2016-08-16

Review 7.  Future Directions of Intraoperative Radiation Therapy: A Brief Review.

Authors:  Tatjana Paunesku; Gayle E Woloschak
Journal:  Front Oncol       Date:  2017-12-12       Impact factor: 6.244

Review 8.  Present state and issues in IORT Physics.

Authors:  Frank W Hensley
Journal:  Radiat Oncol       Date:  2017-01-27       Impact factor: 3.481

Review 9.  Gold Nanoparticles as a Potent Radiosensitizer: A Transdisciplinary Approach from Physics to Patient.

Authors:  Sébastien Penninckx; Anne-Catherine Heuskin; Carine Michiels; Stéphane Lucas
Journal:  Cancers (Basel)       Date:  2020-07-23       Impact factor: 6.639

10.  Intraoperative Radiotherapy With INTRABEAM: Technical and Dosimetric Considerations.

Authors:  Anil Sethi; Bahman Emami; William Small; Tarita O Thomas
Journal:  Front Oncol       Date:  2018-03-26       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.